» Articles » PMID: 35466707

Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes

Overview
Specialty Endocrinology
Date 2022 Apr 25
PMID 35466707
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Accuracy of a seventh-generation "G7" continuous glucose monitoring (CGM) system was evaluated in children and adolescents with type 1 diabetes (T1D).

Methods: Sensors were worn on the upper arm and abdomen. The CGM data were available from 127 of 132 participants, ages 7 to 17 years, across 10.5 days of use, various glucose concentration ranges, and various rates of glucose change for comparisons with temporally matched venous blood glucose measurements (YSI). Data were also available from 28 of 32 participants, ages 2 to 6 years, for whom capillary (fingerstick) blood provided comparator glucose values. Accuracy metrics included the mean absolute relative difference (MARD) between CGM and comparator glucose pairs, the proportion of CGM values within 15 mg/dL or 15% of comparator values <100 or ≥100 mg/dL, respectively, and the analogous %20/20 and %30/30 agreement rates.

Results: For participants aged 7 to 17, a total of 15 437 matched pairs were obtained from 122 arm-placed and 118 abdomen-placed sensors. For arm-placed sensors, the overall MARD was 8.1% and overall %15/15, %20/20, and %30/30 agreement rates were 88.8%, 95.3%, and 98.7%, respectively. For abdomen-placed sensors, the overall MARD was 9.0% and overall %15/15, %20/20, and %30/30 agreement rates were 86.0%, 92.9%, and 97.7%, respectively. Good accuracy was maintained across wear days, glucose ranges, and rates of glucose change. Among those aged 2 to 6, a total of 343 matched pairs provided an overall MARD of 9.3% and an overall %20/20 agreement rate of 91.5%.

Conclusions: The G7 CGM placed on the arm or abdomen was accurate in children and adolescents with T1D. NCT#: NCT04794478.

Citing Articles

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.

Tauschman M, Cardona-Hernandez R, DeSalvo D, Hood K, Laptev D, Lindholm Olinder A Horm Res Paediatr. 2025; 97(6):615-635.

PMID: 39884260 PMC: 11854985. DOI: 10.1159/000543156.


Pre-Type 1 Diabetes in Adolescents and Teens: Screening, Nutritional Interventions, Beta-Cell Preservation, and Psychosocial Impacts.

Sundheim B, Hirani K, Blaschke M, Lemos J, Mittal R J Clin Med. 2025; 14(2).

PMID: 39860389 PMC: 11765808. DOI: 10.3390/jcm14020383.


Continuous Glucose Monitoring-New Diagnostic Tool in Complex Pathophysiological Disorder of Glucose Metabolism in Children and Adolescents with Obesity.

Simunovic M, Kumric M, Rusic D, Paradzik Simunovic M, Bozic J Diagnostics (Basel). 2025; 14(24.

PMID: 39767162 PMC: 11674695. DOI: 10.3390/diagnostics14242801.


Evaluating the precision and reliability of real-time continuous glucose monitoring systems in ambulatory settings: a systematic review.

Davila-Ruales V, Gilon L, Gomez A, Munoz O, Serrano M, Henao D Ther Adv Endocrinol Metab. 2024; 15:20420188241304459.

PMID: 39669532 PMC: 11635893. DOI: 10.1177/20420188241304459.


First Accuracy and User-Experience Evaluation of New Continuous Glucose Monitoring System for Hypoglycemia Due to Hyperinsulinism.

Worth C, Worthington S, Auckburally S, OShea E, Ahmad S, Fullwood C J Diabetes Sci Technol. 2024; :19322968241245923.

PMID: 38616550 PMC: 11572253. DOI: 10.1177/19322968241245923.


References
1.
Tanenbaum M, Zaharieva D, Addala A, Ngo J, Prahalad P, Leverenz B . 'I was ready for it at the beginning': Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis. Diabet Med. 2021; 38(8):e14567. PMC: 8480902. DOI: 10.1111/dme.14567. View

2.
Burckhardt M, Roberts A, Smith G, Abraham M, Davis E, Jones T . The Use of Continuous Glucose Monitoring With Remote Monitoring Improves Psychosocial Measures in Parents of Children With Type 1 Diabetes: A Randomized Crossover Trial. Diabetes Care. 2018; 41(12):2641-2643. DOI: 10.2337/dc18-0938. View

3.
Laffel L, Kanapka L, Beck R, Bergamo K, Clements M, Criego A . Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020; 323(23):2388-2396. PMC: 7298603. DOI: 10.1001/jama.2020.6940. View

4.
Prahalad P, Addala A, Scheinker D, Hood K, Maahs D . CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time. Diabetes Care. 2019; 43(1):e3-e4. PMC: 7011198. DOI: 10.2337/dc19-1205. View

5.
. A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes. Diabetes Care. 2020; 44(2):464-472. PMC: 9162100. DOI: 10.2337/dc20-1060. View